申请人:Rhone-Poulenc Industries
公开号:US04272534A1
公开(公告)日:1981-06-09
Compounds of the formula: ##STR1## wherein R represents hydrogen or alkyl of 1 through 4 carbon atoms, and R.sub.1 and R.sub.2 represent hydrogen or alkyl of 1 through 15 carbon atoms, or alkyl of 1 through 15 carbon atoms substituted by one substituent selected from (i) hydroxy, (ii) alkylamino in which the alkyl radical is of 1 through 4 carbon atoms, (iii) dialkylamino in which the alkyl radicals are of 1 through 4 carbon atoms, (iv) phenyl, (v) carboxy, and (vi) alkoxycarbonyl in which the alkoxy radical is of 1 through 4 carbon atoms, or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached represent a five- or six-membered heterocyclic radical, are new compounds. They possess pharmacological properties and are particularly useful in the treatment of gastro-intestinal ulcers.
式为:##STR1## 其中R代表氢或1到4个碳原子的烷基,R.sub.1和R.sub.2代表氢或1到15个碳原子的烷基,或者1到15个碳原子的烷基被以下一种取代的基团所取代:(i)羟基,(ii)烷基胺,其中烷基基团为1到4个碳原子,(iii)二烷基胺,其中烷基基团为1到4个碳原子,(iv)苯基,(v)羧基,以及(vi)醇酸酯基,其中醇酸酯基团为1到4个碳原子的新化合物。它们具有药理学特性,特别适用于治疗胃肠溃疡。R.sub.1和R.sub.2连同它们所附着的氮原子可以代表一个五元或六元杂环基团。